Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2: Origin, Evolution, and Targeting Inhibition

17 Jun 2021

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak in Wuhan city, China and quickly spread worldwide. Currently, there are no specific drugs or antibodies that claim to cure severe acute respiratory diseases. For SARS-CoV-2, the spike (S) protein recognizes and binds to the angiotensin converting enzyme 2 (ACE2) receptor, allowing viral RNA to enter the host cell. The main protease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34222046
DOI: 10.3389/fcimb.2021.676451

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2: Origin, Evolution, and Targeting InhibitionPMID 34222046Read ↗

SARS-CoV-2: phylogenetic status, mutations and therapeutic research based on spike protein.Semantic proximity Read ↗

Minireview of progress in the structural study of SARS-CoV-2 proteinsSemantic proximity Read ↗

SARS-CoV-2: basic concepts, origin and treatment advancesSemantic proximity Read ↗

SARS-CoV-2: Evolution and Emergence of New Viral Variants.Semantic proximity Read ↗

COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2Semantic proximity Read ↗

SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape MechanismsSemantic proximity Read ↗

Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19Semantic proximity Read ↗

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2Semantic proximity Read ↗

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19Semantic proximity Read ↗

Structural biology of SARS-CoV-2: open the door for novel therapiesSemantic proximity Read ↗

Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.Semantic proximity Read ↗

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.